Takamitsu Nakano

5.0k citations

50 papers · 2.2k indexed · h-index 23

Endocrinology, Diabetes and Metabolism top 1%
Surgery top 5%
Cardiology and Cardiovascular Medicine top 2%
Cancer Research top 5%
Epidemiology top 10%

Co-authors: Katsuyuki Nakajima Akira Tanaka Masakazu Adachi Aki Tamura Motoko Suzuki Toshimitsu SAITO Norio Tada Elisa Campos
Topics: Lipoproteins and Cardiovascular Health (23 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers)Cancer, Lipids, and Metabolism (19 papers)
Cited by: Endocrinology, Diabetes and Metabolism Cancer Research Cardiology and Cardiovascular Medicine
Journals: Circulation The Journal of Clinical Endocrinology & Metabolism FEBS Letters
Partner nations: Japan United States Canada

In The Last Decade

Takamitsu Nakano

50 papers receiving 2.1k citations

Peers

Countries citing papers authored by Takamitsu Nakano

Since Specialization

Citations

This map shows the geographic impact of Takamitsu Nakano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takamitsu Nakano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takamitsu Nakano more than expected).

Fields of papers citing papers by Takamitsu Nakano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takamitsu Nakano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takamitsu Nakano. The network helps show where Takamitsu Nakano may publish in the future.

Co-authorship network of co-authors of Takamitsu Nakano

This figure shows the co-authorship network connecting the top 25 collaborators of Takamitsu Nakano. A scholar is included among the top collaborators of Takamitsu Nakano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takamitsu Nakano. Takamitsu Nakano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia 2015 ·JIMD Reports ·Masa‐aki Kawashiri,Hayato Tada,(unknown),Matsuo Taniyama,Takamitsu Nakano,Katsuyuki Nakajima,Takeshi Inoue,Mika Mori,Chiaki Nakanishi,Tetsuo Konno,Kenshi Hayashi,Atsushi Nohara,Akihiro Inazu,Junji Koizumi,(unknown),Junji Kobayashi,Tsutomu Hirano,Hiroshi Mabuchi,Masakazu Yamagishi	11
2	Plasma adiponectin is a more specific marker of fatty liver than a marker of metabolic syndrome in Japanese men 2013 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·(unknown),Younosuke Shimomura,(unknown),Yukio Ando,Isao Kobayashi,Takamitsu Nakano,Yoshiharu Tokita,Takeaki Nagamine,Hiromi Ono,Akira Tanaka,Ernst J. Schaefer,Katsuyuki Nakajima	8
3	The characteristics of remnant lipoproteins in the fasting and postprandial plasma 2012 ·Clinica Chimica Acta ·Katsuyuki Nakajima,Takamitsu Nakano,Yoshiharu Tokita,Takeaki Nagamine,(unknown),Younosuke Shimomura,Akira Tanaka,Hiroyuki Sumino,Makoto Nara,Tetsuo Machida,Masami Murakami	28
4	Comparative reactivity of remnant-like lipoprotein particles (RLP) and low-density lipoprotein (LDL) to LDL receptor and VLDL receptor: Effect of a high-dose statin on VLDL receptor expression 2011 ·Clinica Chimica Acta ·Michiko Imagawa,Sadao Takahashi,Yasuo Zenimaru,Tomoko Kimura,Jinya Suzuki,Isamu Miyamori,Tadao Iwasaki,Hiroaki Hattori,Tokuo Yamamoto,Takamitsu Nakano,Katsuyuki Nakajima	12
5	The correlation between TG vs remnant lipoproteins in the fasting and postprandial plasma of 23 volunteers 2009 ·Clinica Chimica Acta ·Katsuyuki Nakajima,Takamitsu Nakano,(unknown),Takeaki Nagamine,Kimber L. Stanhope,Peter J. Havel,G. Russell Warnick	30
6	Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor 2009 ·Cancer Epidemiology ·Yoshitaka Sekine,Hidekazu Koike,Takamitsu Nakano,Katsuyuki Nakajima,Sadao Takahashi,Kazuhiro Suzuki	28
7	Dietary salt restriction increases plasma lipoprotein and inflammatory marker concentrations in hypertensive patients 2008 ·Atherosclerosis ·E.R. Nakandakare,(unknown),Flávia Cunha dos Santos,V.S. Nunes,(unknown),Ana Maria Lottenberg,Décio Mion,Takamitsu Nakano,Katsuyuki Nakajima,Élbio Antônio D’Amico,Sérgio Catanozi,Marisa Passarelli,E.C.R. Quintão	38
8	Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells 2007 ·Clinica Chimica Acta ·Yoshitaka Sekine,Hidekazu Koike,Takamitsu Nakano,Katsuyuki Nakajima,Kazuhiro Suzuki	24
9	Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma 2006 ·Clinica Chimica Acta ·Hiroshi Okamoto,(unknown),Tomohiko Sasase,Noboru Furukawa,Mutsuyoshi Matsushita,Takamitsu Nakano,Katsuyuki Nakajima	19
10	The oxidative modification hypothesis of atherosclerosis: The comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma 2006 ·Clinica Chimica Acta ·Katsuyuki Nakajima,Takamitsu Nakano,Akira Tanaka	154
11	Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents 2004 ·Thrombosis Research ·Masako Yamazaki,Shinichiro Uchiyama,Yun Xiong,Takamitsu Nakano,Tomomi Nakamura,Makoto Iwata	22
12	Hypertriglyceridemia in pregnancy does not contribute to the enhanced formation of remnant lipoprotein particles 2003 ·Clinica Chimica Acta ·Mitsuyo Okazaki,Shinichi Usui,Katsuto Tokunaga,Y. Nakajima,Sanae Takeichi,Takamitsu Nakano,Katsuyuki Nakajima	10
13	The human frizzled-3 (FZD3) gene on chromosome 8p21, a receptor gene for Wnt ligands, is associated with the susceptibility to schizophrenia 2003 ·Neuroscience Letters ·Takeshi Katsu,Hiroshi Ujike,Takamitsu Nakano,Yuji Tanaka,Akira Nomura,Kenji Nakata,Manabu Takaki,Ayumu Sakai,Naohiko Uchida,Takaki Imamura,Shigetoshi Kuroda	58
14	Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques 2002 ·Clinica Chimica Acta ·Shinichi Usui,Kazuhiro Suzuki,Hidetoshi Yamanaka,Takamitsu Nakano,Katsuyuki Nakajima,Yukichi Hara,Mitsuyo Okazaki	21
15	Plasma triglyceride-rich lipoprotein remnants as a risk factor of ‘Pokkuri disease’ 2001 ·Legal Medicine ·Sanae Takeichi,Y. Nakajima,Nobuhiro Yukawa,Takeshi Saito,(unknown),Xiu-Lin Huang,Takahiko Kusakabe,(unknown),Iwao Hasegawa,Takamitsu Nakano,Abby R. Saniabadi,Masakazu Adachi,Naoki Ohara,Tao Wang,Katsuyuki Nakajima	22
16	Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC 2000 ·Clinica Chimica Acta ·Mitsuyo Okazaki,Shinichi Usui,Norio Tada,Takamitsu Nakano,Katsuyuki Nakajima	38
17	The Role of Remnant Lipoproteins in Atherosclerosis 2000 ·Annals of the New York Academy of Sciences ·Akio Kawakami,Akira Tanaka,Takamitsu Nakano,Katsuyuki Nakajima,Fujío Numano	1
18	Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death 1999 ·Atherosclerosis ·Sanae Takeichi,Nobuhiro Yukawa,Y. Nakajima,Motoki Osawa,Takeshi Saito,(unknown),Takamitsu Nakano,Abby R. Saniabadi,Masakazu Adachi,(unknown),Katsuyuki Nakajima	73
19	Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels 1993 ·Clinica Chimica Acta ·Katsuyuki Nakajima,Toshimitsu SAITO,Aki Tamura,Motoko Suzuki,Takamitsu Nakano,Masakazu Adachi,Akira Tanaka,Norio Tada,(unknown),Elisa Campos,Richard J. Havel	373
20	Apolipoprotein B-48 analysis by high-performance liquid chromatography in VLDL: a sensitive and rapid method 1990 ·Clinica Chimica Acta ·Hideki Hidaka,Hideto Kojima,(unknown),Takahiko Aoki,Takaaki Nakamura,(unknown),Takamitsu Nakano,Yutaka Harano,Yukio Shigeta	9

About Takamitsu Nakano

Takamitsu Nakano is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery, having authored 50 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (23 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers) and Cancer, Lipids, and Metabolism (19 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Cancer Research (546 citations) and Cardiology and Cardiovascular Medicine (710 citations). Takamitsu Nakano has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Katsuyuki Nakajima, Akira Tanaka, Masakazu Adachi, Aki Tamura, Motoko Suzuki, Toshimitsu SAITO, Norio Tada, Elisa Campos, Richard J. Havel and Peter J. Havel. Their work appears in journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact